Meeting report
Radiological Protection of Tritium 8 January 2009 at the Rutherford Appleton Laboratory Lecture Theatre, Harwell, Oxon Tritium is ubiquitous in the environment due to the interaction of cosmogenic particles with air molecules in the upper atmosphere. It is also released into the environment as a consequence of operations in the nuclear industry and the use and historical testing of nuclear weapons. In addition, we utilise the properties of tritium in a variety of applications ranging from luminising to the radio-labelling of various pharmaceuticals. Clearly, radiological protection from the biological effects of tritium is a varied discipline; this being reflected in the large, multinational turnout for the latest SRP conference.
The conference comprised ten presentations concerning various aspects of radiological protection and decommissioning as well as the biological risks associated with tritium. Delegates were also invited to attend a conference dinner as well as a guided tour around the Rutherford Appleton Laboratory Diamond light source, a 562 metre synchrotron.
The first session of the conference concerned current thinking on the radiotoxicity of tritium, whilst the second consisted a number of presentations on various practical aspects of radiological protection from tritium. A brief summary of these presentations is given below.
Prof Richard Wakeford (chairman) of the University of Manchester opened the first session with an introduction on the sources of tritium. This provided an excellent overview; allowing the following presentations to diverge into technical aspects and current research into biological risks.
Dr John Harrison (Health Protection Agency), Dr Barrie Lambert and Prof Dudley Goodhead (Medical Research Council) delivered detailed presentations concerning the biological effectiveness of low energy beta particles, such as those emitted by the radioactive decay of tritium. Opinions are clearly mixed regarding the need to increase the radiation weighting factor (W R ) for tritium to greater than one. Evidence suggests that the relative biological effectiveness (RBE) of tritium is approximately two compared to 60 Co gamma rays; this being due to the increased linear density of ionisation at the cellular level (maximum track length is 6 μm, compared with typical cellular dimensions of 10-20 μm). However, it is the ICRP's current standing that, for the purpose of protection quantities, the W R for tritium should remain as that for other low LET radiations.
Dr Bernard Le Guen (EDF Medical Advisor) explained the impact of tritium discharges around nuclear power plants in France and Dan Galeriu of IFIN-HH Romania described a metabolic model for the bodily retention of tritium in it's various chemical forms. The session closed with an open forum which provided an opportunity for further debate on tritium weighting factors.
As chairman for the afternoon session, Sheila Liddle introduced a number of speakers from across the nuclear industry to deliver presentations on various practical aspects of protection from tritium. Being an isotope of hydrogen, tritium exhibits significant mobility in the environment as well as existing in a variety of chemical forms, ranging from elemental tritium and tritiated water to organically bound variants. Coupled to this the difficulties associated with tritium detection, and the intricacies of practical radiological protection from this hazard become apparent.
Representing JET, Darryl Campling explained some of the tritium issues involved in fusion research, not least the production of tritiated dust particles. Containment, ventilation, monitoring and waste management were all covered in a presentation by Dr Dominic Jones (AWE) on the challenges of designing tritium handling facilities. An emphasis was placed on the need to consider decommissioning issues at the early design stages, hence ensuring restriction of exposure over the entire life cycle of the facility. Following on from this, Dr Ian Bonnett (GE Healthcare) described a number of solutions for tritium recovery and recycling.
An interesting and informative presentation on a fire in a tritium facility was delivered by Gareth Thomas of the Health and Safety Executive. Describing the accident itself, the spread of contamination, remediation and waste disposal; Gareth concluded by summarizing the lessons learnt from this particular case. On a similar subject, Penny Oliver (Nuvia) presented a case study on tritium decommissioning and decontamination. This detailed the methodologies used in the characterization and subsequent remediation of a facility used for the generation of tritiated components. This served as a fine ending to the conference, drawing together a lot of the practical aspects of radiological protection from tritium which had been described throughout the day.
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